Pengcheng Xun1, Ying Wu, Qianchuan He, Ka He. 1. Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN (PX and KH); the Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (YW); and the Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (QH).
Abstract
BACKGROUND: Insulin resistance is a precursor of numerous chronic diseases, including cardiovascular disease (CVD). The fasting insulin concentration is considered a reasonable surrogate of insulin resistance, especially among nondiabetic individuals. OBJECTIVE: We aimed to quantitatively summarize the literature on the association of fasting insulin concentrations with risk of hypertension, stroke, and coronary heart disease (CHD) by conducting a meta-analysis of prospective cohort studies. DESIGN: Eligible studies were identified by searching PubMed and EMBASE through January 2013. Additional information was retrieved through Google Scholar or a hand review of the reference lists from relevant articles. Prospective cohort studies that reported RRs and corresponding 95% CIs for the association of interest were identified. Data were extracted independently by 2 investigators, and the weighted RRs and 95% CIs for the associations were obtained by using a random-effects model. RESULTS: Of the 22 identified studies, 10 reported results on hypertension (36,617 individuals and 4491 cases), 7 on stroke (27,887 individuals and 1550 cases), and 9 on CHD (22,379 individuals and 1986 cases). Comparison of the highest with the lowest quantile of fasting insulin concentrations showed a pooled RR (95% CI) of 1.63 (1.35, 1.97) for hypertension, 1.18 (0.87, 1.60) for stroke, and 1.50 (1.28, 1.77) for CHD. Each 50-pmol/L increment in fasting insulin was associated with a 25% increase in risk of hypertension [RR: 1.25 (1.14, 1.36)] and a 16% increase in risk of CHD [RR: 1.16 (1.10, 1.22)] but was not associated with risk of stroke [RR: 0.999 (0.99, 1.01)]. CONCLUSIONS: A higher fasting insulin concentration or hyperinsulinemia was significantly associated with an increased risk of hypertension and CHD but not stroke. This meta-analysis suggests that early fasting insulin ascertainment in the general population may help clinicians identify those who are potentially at high risk of CVD.
BACKGROUND:Insulin resistance is a precursor of numerous chronic diseases, including cardiovascular disease (CVD). The fasting insulin concentration is considered a reasonable surrogate of insulin resistance, especially among nondiabetic individuals. OBJECTIVE: We aimed to quantitatively summarize the literature on the association of fasting insulin concentrations with risk of hypertension, stroke, and coronary heart disease (CHD) by conducting a meta-analysis of prospective cohort studies. DESIGN: Eligible studies were identified by searching PubMed and EMBASE through January 2013. Additional information was retrieved through Google Scholar or a hand review of the reference lists from relevant articles. Prospective cohort studies that reported RRs and corresponding 95% CIs for the association of interest were identified. Data were extracted independently by 2 investigators, and the weighted RRs and 95% CIs for the associations were obtained by using a random-effects model. RESULTS: Of the 22 identified studies, 10 reported results on hypertension (36,617 individuals and 4491 cases), 7 on stroke (27,887 individuals and 1550 cases), and 9 on CHD (22,379 individuals and 1986 cases). Comparison of the highest with the lowest quantile of fasting insulin concentrations showed a pooled RR (95% CI) of 1.63 (1.35, 1.97) for hypertension, 1.18 (0.87, 1.60) for stroke, and 1.50 (1.28, 1.77) for CHD. Each 50-pmol/L increment in fasting insulin was associated with a 25% increase in risk of hypertension [RR: 1.25 (1.14, 1.36)] and a 16% increase in risk of CHD [RR: 1.16 (1.10, 1.22)] but was not associated with risk of stroke [RR: 0.999 (0.99, 1.01)]. CONCLUSIONS: A higher fasting insulin concentration or hyperinsulinemia was significantly associated with an increased risk of hypertension and CHD but not stroke. This meta-analysis suggests that early fasting insulin ascertainment in the general population may help clinicians identify those who are potentially at high risk of CVD.
Authors: C Ferri; V Pittoni; A Piccoli; O Laurenti; M R Cassone; C Bellini; G Properzi; G Valesini; G De Mattia; A Santucci Journal: J Clin Endocrinol Metab Date: 1995-03 Impact factor: 5.958
Authors: Hilary A Tindle; Meredith S Duncan; Simin Liu; Lewis H Kuller; Nancy Fugate Woods; Steve R Rapp; Candyce H Kroenke; Mace Coday; Eric B Loucks; Michael J Lamonte; Ana M Progovac; Elena Salmoirago-Blotcher; Brian T Walitt; Nai-Chieh Y Yuo; Matthew S Freiberg Journal: J Diabetes Date: 2017-09-29 Impact factor: 4.006
Authors: Barbara A Gower; Keith Pearson; Nikki Bush; James M Shikany; Virginia J Howard; Caroline W Cohen; Stephanie E Tison; George Howard; Suzanne Judd Journal: Eur J Clin Nutr Date: 2020-10-06 Impact factor: 4.016
Authors: Ranee Chatterjee; Mary L Biggs; Ian H de Boer; Frederick L Brancati; Laura P Svetkey; Joshua Barzilay; Luc Djoussé; Joachim H Ix; Jorge R Kizer; David S Siscovick; Dariush Mozaffarian; David Edelman; Kenneth J Mukamal Journal: J Gerontol A Biol Sci Med Sci Date: 2014-06-03 Impact factor: 6.053
Authors: Nora E Straznicky; Mariee T Grima; Carolina I Sari; Elisabeth A Lambert; Sarah E Phillips; Nina Eikelis; Daisuke Kobayashi; Dagmara Hering; Justin A Mariani; John B Dixon; Paul J Nestel; Sofie Karapanagiotidis; Markus P Schlaich; Gavin W Lambert Journal: Cardiovasc Diabetol Date: 2015-08-22 Impact factor: 9.951